Indeed, a higher ratio of GZMK+ CD8+ T cells to exhausted T cells is positively correlated with improved survival rates in patients with non-small cell lung cancer and is linked to better responses to immune checkpoint inhibitors in melanoma patients (Figure 1). Here, CD8A is linked to melanoma.